These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38349529)

  • 1. Mechanisms of antifungal resistance and developments in alternative strategies to combat Candida albicans infection.
    Sharma K; Parmanu PK; Sharma M
    Arch Microbiol; 2024 Feb; 206(3):95. PubMed ID: 38349529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
    Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro evaluation of virulence markers and antifungal resistance of clinical Candida albicans strains isolated from Karachi, Pakistan.
    Jabeen G; Naz SA; Rangel DEN; Jabeen N; Shafique M; Yasmeen K
    Fungal Biol; 2023; 127(7-8):1241-1249. PubMed ID: 37495314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
    Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Candida albicans filamentation for antifungal drug development.
    Vila T; Romo JA; Pierce CG; McHardy SF; Saville SP; Lopez-Ribot JL
    Virulence; 2017 Feb; 8(2):150-158. PubMed ID: 27268130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
    Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
    Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm of Candida albicans: formation, regulation and resistance.
    Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
    J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Candida albicans biofilm.
    Tsui C; Kong EF; Jabra-Rizk MA
    Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
    Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
    Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-virulence strategy of diaryl chalcogenide compounds against
    Song S; Zhao S; Sun X; Meng L; Wang Z; Tan H; Liu J; Zhang M; Deng Y
    Virulence; 2023 Dec; 14(1):2265012. PubMed ID: 37771181
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections.
    Feng Y; Lu H; Whiteway M; Jiang Y
    J Glob Antimicrob Resist; 2023 Dec; 35():314-321. PubMed ID: 37918789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
    Lee JH; Kim YG; Lee J
    Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Response of
    Salama OE; Gerstein AC
    Antimicrob Agents Chemother; 2022 May; 66(5):e0240621. PubMed ID: 35446135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
    Mohammadi F; Hemmat N; Bajalan Z; Javadi A
    Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model.
    Gomaa SE; Abbas HA; Mohamed FA; Ali MAM; Ibrahim TM; Abdel Halim AS; Alghamdi MA; Mansour B; Chaudhary AA; Elkelish A; Boufahja F; Hegazy WAH; Yehia FAA
    BMC Microbiol; 2024 Feb; 24(1):54. PubMed ID: 38341568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
    Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
    J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.